TIDES is the largest event and conference for oligonucleotide and peptide product development and commercialization.
JenKem Technology will showcase its capabilities for manufacture and global distribution of high purity PEGs, monodisperse (discrete) PEGs, PEG co-polymers and derivatives, from laboratory through large GMP commercial scale, and PEGylation services for peptides and oligonucleotides.
A poster on “Novel Cell-Penetrating Drug Delivery System for siRNA” was presented by JenKem Technology and Tianjin Medical University at the 2018 TIDES meeting, introducing our patented Cell Penetrating Peptide PEG nonviral gene delivery reagents.
We look forward to seeing you at TIDES to learn how we can meet your high quality PEG and PEGylation needs.
JenKem Technology specializes in the development and manufacture of high-quality polyethylene glycol (PEG) derivatives, and related custom synthesis and PEGylation services. JenKem Technology is ISO 9001 and ISO 13485 certified and adheres to ICH Q7A guidelines for GMP manufacture. The production of JenKem® PEGs is back integrated to in-house polymerization from ethylene oxide to ensure batch to batch consistency. JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through large commercial scale.